Quest Diagnostics (NYSE:DGX) Cut to "Hold" at StockNews.com

StockNews.com lowered shares of Quest Diagnostics (NYSE:DGX – Free Report) from a buy rating to a hold rating in a research report released on Friday. Other research analysts also recently issued research reports about the stock. Truist Financial increased their price objective on shares of Quest Diagnostics from $145.00 to $150.00 and gave the company […]

Related Keywords

United States , Vickyb Gregg , Karthik Kuppusamy , Visionpoint Advisory Group , Wealth Management , Securities Inc , Altshuler Shaham Ltd , Quest Diagnostics Company Profile , Securities Exchange Commission , Quest Diagnostics Incorporated , Quest Diagnostics , Free Report , Get Free Report , Exchange Commission , Director Vicky , Shaham Ltd , Point Advisory Group , Spartan Planning , Diagnostics Incorporated , Quest Diagnostics Daily , Nyse Dgx , Dgx , Medical , 74834l10 , Downgrade , Stocknews Com ,